6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/20252025 Outlook for Medtech in China (Simon Kucher)

5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Recent Official and Executive Moves

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China

5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...

5/29/2025China Grants Conditional Approval to Hengrui's Famitinib

5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million

5/28/2025Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...

5/28/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...

5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939

5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...

5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova

5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...

5/27/2025RemeGen's Telitacicept Gains Approval in China

5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia

Page:10/367 Total number of articles:10998: [First][<<] [8] [9] [10] [11] [12] [>>] [End]